Alvotech resolves global patent disputes with Regeneron and Bayer over Eylea biosimilar
Source: SeekingAlpha
2026-01-29 03:25:39 ET
Read the full article on Seeking Alpha
For further details see:
Alvotech resolves global patent disputes with Regeneron and Bayer over Eylea biosimilar
Alvotech
NASDAQ: ALVO
ALVO Trading
2.99% G/L:
$3.445 Last:
85,023 Volume:
$3.35 Open:
ALVO Latest News
ALVO Stock Data
$1,569,389,520
107,654,085
N/A
30
N/A
Pharmaceuticals
Healthcare
LU
Luxembourg
